Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) last traded at $13.00, up 14.64% on the session. The quote above updates while this page is open; the figures below are drawn from Ginkgo Bioworks Holdings, Inc.’s own filings and are restated only when a new one is published.
Ginkgo Bioworks Holdings, Inc. trades on NYSE under the ticker DNA. Its market capitalisation is $828.24 million.
Valuation measures for Ginkgo Bioworks Holdings, Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $828.24M |
|---|---|
| Enterprise value | $1.31B |
| Price / sales | 7.40 |
| Price / book | 1.97 |
| Beta | 2.90 |
Trailing-twelve-month figures tagged in Ginkgo Bioworks Holdings, Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $111.86M |
|---|---|
| Net income (TTM) | -$290.80M |
| EPS (TTM) | -$5.00 |
| Operating margin | -273.61% |
| Return on equity | -69.19% |
| Cash | $84.53M |
Range and volume for DNA over the past 52 weeks.
| 52-week high | $18.22 |
|---|---|
| 52-week low | $5.37 |
| Volume | 4.51M |
| Average volume | 1.84M |
| Previous close | $11.34 |
Invest a chosen dollar amount in Ginkgo Bioworks Holdings, Inc. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell DNA.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.